Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Université de Sherbrooke

$26,000.00

Understanding the fundamental mechanisms of viral activation in the host

EF 2012-13

Résumé
Although much research has been done on the influenza virus over the years, strikingly very little is known about the way the influenza fusion protein hemagglutinin is processed by host enzymes for it to become infectious. Furthermore, only recently have some of the host influenza activating enzymes been identified. We have identified one such enzyme in the cells lining the respiratory tract of humans. To date the current dogma on influenza hemagglutinin activation by host enzymes is that the amino acid sequence present at the cleavage site dictates the type of enzyme that will carry out the activation of the fusion protein. Based on the literature and on our most recent discoveries, we believe that this view of hemagglutinin activation is overly simplistic and that there exist other crucial determinants of viral hemagglutinin and host enzyme interaction, which lead to the protein's processing and activation. In this proposal we aim to elucidate the forces that govern this interaction process and the structural features of influenza hemagglutinin that influence and that are critical for the interaction to take place. To do so, we will use sophisticated and cutting-edge biochemical, biophysical and molecular techniques to study the interaction of H1 and H3 subtype viruses with two influenza-activating enzymes of the host, one that has been identified a few years ago and one that we have newly identified recently. Thus the long-term goal of this research program is to understand the fundamental forces, structural determinants and mechanisms of the interaction of viral fusion proteins with host enzymes, which lead to their activation. This research program should have a significant impact on the field of virology by providing fundamental information on how viral proteins interact with enzymes that activate them in the host. It should also provide vital information to researchers in both academic settings and in the biotech/pharmaceutical sectors who are interested in developing novel influenza antivirals. Canadians will benefit from this research economically through the generation of novel Canadian intellectual property, and in public health through the future development of new antiviral therapies.
Programme
Discovery Grants Program - Individual
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
418127-2012
Name nom
Richter, Martin
Department département
Médecine
Organization id
68
Institution établissement
Université de Sherbrooke
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
26000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5202
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Virology
Research subject fr
Virologie
Partie
1
Nb partie
5
Application title
Understanding the fundamental mechanisms of viral activation in the host
Keyword
NSERC
Application summary
Although much research has been done on the influenza virus over the years, strikingly very little is known about the way the influenza fusion protein hemagglutinin is processed by host enzymes for it to become infectious. Furthermore, only recently have some of the host influenza activating enzymes been identified. We have identified one such enzyme in the cells lining the respiratory tract of humans. To date the current dogma on influenza hemagglutinin activation by host enzymes is that the amino acid sequence present at the cleavage site dictates the type of enzyme that will carry out the activation of the fusion protein. Based on the literature and on our most recent discoveries, we believe that this view of hemagglutinin activation is overly simplistic and that there exist other crucial determinants of viral hemagglutinin and host enzyme interaction, which lead to the protein's processing and activation. In this proposal we aim to elucidate the forces that govern this interaction process and the structural features of influenza hemagglutinin that influence and that are critical for the interaction to take place. To do so, we will use sophisticated and cutting-edge biochemical, biophysical and molecular techniques to study the interaction of H1 and H3 subtype viruses with two influenza-activating enzymes of the host, one that has been identified a few years ago and one that we have newly identified recently. Thus the long-term goal of this research program is to understand the fundamental forces, structural determinants and mechanisms of the interaction of viral fusion proteins with host enzymes, which lead to their activation. This research program should have a significant impact on the field of virology by providing fundamental information on how viral proteins interact with enzymes that activate them in the host. It should also provide vital information to researchers in both academic settings and in the biotech/pharmaceutical sectors who are interested in developing novel influenza antivirals. Canadians will benefit from this research economically through the generation of novel Canadian intellectual property, and in public health through the future development of new antiviral therapies.